Sunshine Heart - First U.S. C-Pulse Implants
Sunshine Heart reports the first two US implants of its C-Pulse heart assist device, performed at Ohio State under a 20-patient FDA-approved feasibility trial running across six American hospitals.
Company
Columbus, OS
Every investor coverage indicates participated in a round Ohio State University Medical Center raised.
Companies Ohio State University Medical Center acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Ohio State University Medical Center. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Sunshine Heart reports the first two US implants of its C-Pulse heart assist device, performed at Ohio State under a 20-patient FDA-approved feasibility trial running across six American hospitals.
ASX-listed heart device maker Sunshine Heart has finished training clinicians at six US hospitals ahead of its C-Pulse feasibility trial, planned to start later in 2007.